Oxford Biodynamics (OBD) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Oct 2024 12:12 PM
RNS
Director / PDMR holdings and Total Voting Rights
25 Oct 2024 07:00 AM
RNS
Prognostic Covid Severity Test Study Published
22 Oct 2024 01:00 PM
RNS
CiRT Receives Clinical Approval from NYS CLEP
15 Oct 2024 02:34 PM
RNS
Holding(s) in Company
14 Oct 2024 07:00 AM
RNS
Commercial update for FY24
07 Oct 2024 07:01 AM
RNS
Holding(s) in Company
07 Oct 2024 07:00 AM
RNS
CIRRP Award Update
11 Sep 2024 12:55 PM
RNS
Holding(s) in Company
22 Aug 2024 04:59 PM
RNS
Holding(s) in Company
22 Aug 2024 11:41 AM
RNS
Holding(s) in Company
25 Jul 2024 07:00 AM
RNS
OBD pursuing EpiSwitch as companion diagnostics
21 Jun 2024 03:42 PM
RNS
Grant of Options
18 Jun 2024 07:00 AM
RNS
Half-year Report
06 Jun 2024 07:00 AM
RNS
OBD's PSE test to be used in NCI trial
04 Jun 2024 07:00 AM
RNS
OBD develops multi-cancer diagnostic test for dogs
24 May 2024 07:00 AM
RNS
Notice of Results
23 May 2024 07:00 AM
RNS
OBD partners with Goodbody Clinic on PSE test
21 May 2024 07:00 AM
RNS
OBD partners with The London Clinic for PSE & CiRT
16 May 2024 07:00 AM
RNS
OBD and King's College London collaborate on RA
10 May 2024 01:11 PM
RNS
Holding(s) in Company
25 Apr 2024 02:50 PM
RNS
Holding(s) in Company
11 Apr 2024 02:36 PM
RNS
Holding(s) in Company
10 Apr 2024 04:28 PM
RNS
Holding(s) in Company
09 Apr 2024 05:35 PM
RNS
Holding(s) in Company
09 Apr 2024 12:42 PM
RNS
Holding(s) in Company
09 Apr 2024 11:56 AM
RNS
Holding(s) in Company
05 Apr 2024 04:52 PM
RNS
Holding(s) in Company
05 Apr 2024 08:28 AM
RNS
Holding(s) in Company
03 Apr 2024 12:57 PM
RNS
Results of GM
03 Apr 2024 07:00 AM
RNS
OBD opens UK clinical testing facility
27 Mar 2024 02:18 PM
RNS
Result of AGM
14 Mar 2024 07:00 AM
RNS
Results of Fundraising
13 Mar 2024 04:45 PM
RNS
PrimaryBid Offer
13 Mar 2024 04:40 PM
RNS
Proposed Fundraising
22 Feb 2024 02:30 PM
RNS
Annual Report & Accounts
17 Jan 2024 07:00 AM
RNS
Preliminary Results and Notice of AGM
21 Dec 2023 07:20 AM
RNS
Notice of Results
13 Nov 2023 10:22 AM
RNS
Director/PDMR Shareholding
08 Nov 2023 07:00 AM
RNS
OBD strengths commercial leadership
07 Nov 2023 12:30 PM
RNS
Holding(s) in Company
06 Nov 2023 05:04 PM
RNS
Holding(s) in Company
03 Nov 2023 09:29 AM
RNS
Director/PDMR Shareholding
23 Oct 2023 11:09 AM
RNS
PDMR Dealing / Grant of Share Options
20 Oct 2023 09:45 AM
RNS
Director/PDMR Shareholding
18 Oct 2023 07:00 AM
RNS
Bupa UK to cover EpiSwitch® CiRT for customers
06 Oct 2023 05:44 PM
RNS
Director/PDMR Shareholding
03 Oct 2023 04:37 PM
RNS
Holding(s) in Company
03 Oct 2023 07:00 AM
RNS
OBD receives reimbursement code for PSE test
26 Sep 2023 07:00 AM
RNS
OBD launches 94% accurate PSE test in US and UK
07 Sep 2023 10:18 AM
RNS
Holding(s) in Company

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

UK 100

Latest directors dealings